BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Handschin C, Lin J, Rhee J, Peyer AK, Chin S, Wu PH, Meyer UA, Spiegelman BM. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell. 2005;122:505-515. [PMID: 16122419 DOI: 10.1016/j.cell.2005.06.040] [Cited by in Crossref: 267] [Cited by in F6Publishing: 276] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Brenner DM, Brandt LJ, Fenster M, Hamilton MJ, Kamboj AK, Oxentenko AS, Wang B, Chey WD. Rare, Overlooked, or Underappreciated Causes of Recurrent Abdominal Pain: A Primer for Gastroenterologists. Clin Gastroenterol Hepatol 2023;21:264-79. [PMID: 36180010 DOI: 10.1016/j.cgh.2022.09.022] [Reference Citation Analysis]
2 Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating Glycolysis to Improve Cancer Therapy. IJMS 2023;24:2606. [DOI: 10.3390/ijms24032606] [Reference Citation Analysis]
3 Wang B, Bonkovsky HL, Lim JK, Balwani M. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. Gastroenterology 2023:S0016-5085(22)01356-7. [PMID: 36642627 DOI: 10.1053/j.gastro.2022.11.034] [Reference Citation Analysis]
4 Baidya S, Kandel P, Rajkarnikar S, Kadel A, Niraula A, Dubey RK, Lamichhane M, Raut M, Bhattarai A, Tuladhar ET, Sharma VK. Porphyria: a case report. J Med Case Rep 2022;16:490. [PMID: 36575494 DOI: 10.1186/s13256-022-03708-w] [Reference Citation Analysis]
5 Solares I, Jericó D, Córdoba KM, Morales-Conejo M, Ena J, Enríquez de Salamanca R, Fontanellas A. Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria. Int J Mol Sci 2022;24. [PMID: 36613492 DOI: 10.3390/ijms24010051] [Reference Citation Analysis]
6 Neeleman R, Musters K, Wagenmakers M, Mijnhout S, Friesema E, Sijbrands E, Langendonk J. Mortality in Pedigrees with Acute Intermittent Porphyria. Life (Basel) 2022;12. [PMID: 36556425 DOI: 10.3390/life12122059] [Reference Citation Analysis]
7 Bennett CF, Latorre-Muro P, Puigserver P. Mechanisms of mitochondrial respiratory adaptation. Nat Rev Mol Cell Biol 2022;23:817-35. [PMID: 35804199 DOI: 10.1038/s41580-022-00506-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jericó D, Córdoba KM, Sampedro A, Jiang L, Joucla G, Cabanne C, Lanciego JL, Martini PGV, Berraondo P, Ávila MA, Fontanellas A. Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment. Life (Basel) 2022;12. [PMID: 36430993 DOI: 10.3390/life12111858] [Reference Citation Analysis]
9 Acevedo Ospina H, Guay-Vincent MM, Descoteaux A. Macrophage Mitochondrial Biogenesis and Metabolic Reprogramming Induced by Leishmania donovani Require Lipophosphoglycan and Type I Interferon Signaling. mBio 2022;:e0257822. [PMID: 36222510 DOI: 10.1128/mbio.02578-22] [Reference Citation Analysis]
10 Ricci A, Di Betto G, Bergamini E, Buzzetti E, Corradini E, Ventura P. Iron Metabolism in the Disorders of Heme Biosynthesis. Metabolites 2022;12:819. [DOI: 10.3390/metabo12090819] [Reference Citation Analysis]
11 Storjord E, Airila-Månsson S, Karlsen K, Madsen M, Dahl JA, Landsem A, Fure H, Ludviksen JK, Fjøse JØ, Dickey AK, Karlsen BO, Waage Nielsen E, Mollnes TE, Brekke OL. Dental and Periodontal Health in Acute Intermittent Porphyria. Life (Basel) 2022;12:1270. [PMID: 36013449 DOI: 10.3390/life12081270] [Reference Citation Analysis]
12 Petrides PE. Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know. Diagnostics 2022;12:1618. [DOI: 10.3390/diagnostics12071618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kubisch I, Stölzel U. Porphyrien erkennen und therapieren. Gastro-News 2022;9:34-39. [DOI: 10.1007/s15036-022-2500-8] [Reference Citation Analysis]
14 Ricci A, Sandri G, Marcacci M, Di Pierro E, Granata F, Cuoghi C, Marchini S, Pietrangelo A, Ventura P. Endothelial Dysfunction in Acute Hepatic Porphyrias. Diagnostics 2022;12:1303. [DOI: 10.3390/diagnostics12061303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schulenburg-Brand D, Stewart F, Stein P, Rees D, Badminton M. Update on the diagnosis and management of the autosomal dominant acute hepatic porphyrias. J Clin Pathol 2022:jclinpath-2021-207647. [PMID: 35584894 DOI: 10.1136/jclinpath-2021-207647] [Reference Citation Analysis]
16 Andrejic O, Vucic R, Cupic VI, Davidovic G. Hypertensive Crisis in Patients with Acute Intermittent Porphyria. Serbian Journal of Experimental and Clinical Research 2022;23:89-91. [DOI: 10.2478/sjecr-2017-0039] [Reference Citation Analysis]
17 Goga A, Stoffel M. Therapeutic RNA-silencing oligonucleotides in metabolic diseases. Nat Rev Drug Discov 2022. [PMID: 35210608 DOI: 10.1038/s41573-022-00407-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sardh E, Harper P. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria. J Intern Med. [DOI: 10.1111/joim.13443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sirch C, Khanna N, Frassetto L, Bianco F, Artero ML. Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report. World J Transplant 2022; 12(1): 8-14 [DOI: 10.5500/wjt.v12.i1.8] [Reference Citation Analysis]
20 Stölzel U, Kubisch I, Stauch T, Schuppan D. Disorders of Heme Metabolism. Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases 2022. [DOI: 10.1007/978-3-030-67727-5_57] [Reference Citation Analysis]
21 Vagany V, Robinson S, Chernova T, Smith AG. Complex response to physiological and drug-induced hepatic heme demand in monoallelic ALAS1 mice. Mol Genet Metab Rep 2021;29:100818. [PMID: 34900592 DOI: 10.1016/j.ymgmr.2021.100818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ricci A, Di Pierro E, Marcacci M, Ventura P. Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias. Diagnostics (Basel) 2021;11:2205. [PMID: 34943446 DOI: 10.3390/diagnostics11122205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
23 Kuo HC, Lin CN, Tang YF. Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria. Front Pharmacol 2021;12:712305. [PMID: 34690757 DOI: 10.3389/fphar.2021.712305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jericó D, Córdoba KM, Jiang L, Schmitt C, Morán M, Sampedro A, Alegre M, Collantes M, Santamaría E, Alegre E, Culerier C, de Mendoza AE, Oyarzabal J, Martín MA, Peñuelas I, Ávila MA, Gouya L, Martini PGV, Fontanellas A. mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks. Mol Ther Nucleic Acids 2021;25:207-19. [PMID: 34458006 DOI: 10.1016/j.omtn.2021.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Vassiliou D, Sardh E. Acute hepatic porphyria and maternal health: Clinical and biochemical follow-up of 44 pregnancies. J Intern Med 2021. [PMID: 34411356 DOI: 10.1111/joim.13376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Wang T, Ashrafi A, Modareszadeh P, Deese AR, Chacon Castro MDC, Alemi PS, Zhang L. An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases. Cancers (Basel) 2021;13:4142. [PMID: 34439295 DOI: 10.3390/cancers13164142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Stölzel U, Stauch T, Kubisch I. [Porphyria]. Internist (Berl) 2021;62:937-51. [PMID: 34185109 DOI: 10.1007/s00108-021-01066-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhang J, Jiao L, Song J, Wu T, Bai H, Liu T, Zhao Z, Hu X, Ying B. Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity. Evid Based Complement Alternat Med 2021;2021:3185874. [PMID: 34249128 DOI: 10.1155/2021/3185874] [Reference Citation Analysis]
29 Mota BC, Sastre M. The Role of PGC1α in Alzheimer's Disease and Therapeutic Interventions. Int J Mol Sci 2021;22:5769. [PMID: 34071270 DOI: 10.3390/ijms22115769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Lu MY, Xu L, Qi GH, Zhang HJ, Qiu K, Wang J, Wu SG. Mechanisms associated with the depigmentation of brown eggshells: a review. Poult Sci 2021;100:101273. [PMID: 34214744 DOI: 10.1016/j.psj.2021.101273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Albuquerque A, Óvilo C, Núñez Y, Benítez R, López-Garcia A, García F, Félix MDR, Laranjo M, Charneca R, Martins JM. Transcriptomic Profiling of Skeletal Muscle Reveals Candidate Genes Influencing Muscle Growth and Associated Lipid Composition in Portuguese Local Pig Breeds. Animals (Basel) 2021;11:1423. [PMID: 34065673 DOI: 10.3390/ani11051423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
32 Wang B. Novel treatment options for acute hepatic porphyrias. Curr Opin Gastroenterol 2021;37:194-9. [PMID: 33769375 DOI: 10.1097/MOG.0000000000000734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Bideyan L, Nagari R, Tontonoz P. Hepatic transcriptional responses to fasting and feeding. Genes Dev 2021;35:635-57. [PMID: 33888557 DOI: 10.1101/gad.348340.121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
34 Kopylchuk G, Yuriy Fedkovych Chernivtsi National University, Ukraine, Grynenkiv ZI, Voloshchuk O, Yuriy Fedkovych Chernivtsi National University, Ukraine, Yuriy Fedkovych Chernivtsi National University, Ukraine. CYTOCHROMES OF MITOCHONDRIES AND ACTIVITY OF HEME METABOLISM ENZYMES IN THE LIVER UNDER DIFFERENT NUTRIENT REGIMES. Fiziol Zh 2021;67:37-43. [DOI: 10.15407/fz67.02.037] [Reference Citation Analysis]
35 Wang B. The acute hepatic porphyrias. Transl Gastroenterol Hepatol 2021;6:24. [PMID: 33824928 DOI: 10.21037/tgh-2020-01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Desnick RJ, Balwani M, Anderson KE. Heme Biosynthesis and the Porphyrias in Children. Liver Disease in Children 2021. [DOI: 10.1017/9781108918978.030] [Reference Citation Analysis]
37 Huang J, Zheng C, Luo R, Liu M, Gu Q, Li J, Wu X, Yang Z, Shen X, Li X. Integrative analyses identify potential key genes and pathways in Keshan disease using whole-exome sequencing.. [DOI: 10.1101/2021.03.12.21253491] [Reference Citation Analysis]
38 Solares I, Izquierdo-Sánchez L, Morales-Conejo M, Jericó D, Castelbón FJ, Córdoba KM, Sampedro A, Lumbreras C, Moreno-Aliaga MJ, Enríquez de Salamanca R, Berraondo P, Fontanellas A. High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach. Biomedicines 2021;9:255. [PMID: 33807619 DOI: 10.3390/biomedicines9030255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
39 McMeekin LJ, Fox SN, Boas SM, Cowell RM. Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities. Cells 2021;10:352. [PMID: 33572179 DOI: 10.3390/cells10020352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
40 Bustad HJ, Kallio JP, Vorland M, Fiorentino V, Sandberg S, Schmitt C, Aarsand AK, Martinez A. Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators. Int J Mol Sci 2021;22:E675. [PMID: 33445488 DOI: 10.3390/ijms22020675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
41 de Carvalho SS, Rodovalho CM, Gaviraghi A, Mota MBS, Jablonka W, Rocha-Santos C, Nunes RD, Sá-Guimarães TDE, Oliveira DS, Melo ACA, Moreira MF, Fampa P, Oliveira MF, da Silva-Neto MAC, Mesquita RD, Atella GC. Aedes aegypti post-emergence transcriptome: Unveiling the molecular basis for the hematophagic and gonotrophic capacitation. PLoS Negl Trop Dis 2021;15:e0008915. [PMID: 33406161 DOI: 10.1371/journal.pntd.0008915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Moghe A, Anderson KE. Porphyrias: Acute Manifestations. Contemporary Endocrinology 2021. [DOI: 10.1007/978-3-030-67455-7_20] [Reference Citation Analysis]
43 Desnick RJ, Balwani M, Anderson KE. Inherited Porphyrias. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2021. [DOI: 10.1016/b978-0-12-812535-9.00010-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Peoc'h K, Puy V, Fournier T. Haem oxygenases play a pivotal role in placental physiology and pathology. Hum Reprod Update 2020;26:634-49. [PMID: 32347305 DOI: 10.1093/humupd/dmaa014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Tai-Nagara I, Hasumi Y, Kusumoto D, Hasumi H, Okabe K, Ando T, Matsuzaki F, Itoh F, Saya H, Liu C, Li W, Mukouyama YS, Marston Linehan W, Liu X, Hirashima M, Suzuki Y, Funasaki S, Satou Y, Furuya M, Baba M, Kubota Y. Blood and lymphatic systems are segregated by the FLCN tumor suppressor. Nat Commun 2020;11:6314. [PMID: 33298956 DOI: 10.1038/s41467-020-20156-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wilson-Baig N, Badminton M, Schulenburg-Brand D. Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks. BJA Educ 2021;21:66-74. [PMID: 33889432 DOI: 10.1016/j.bjae.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Lu MY, Wang WW, Qi GH, Xu L, Wang J. Mitochondrial transcription factor A induces the declined mitochondrial biogenesis correlative with depigmentation of brown eggshell in aged laying hens. Poult Sci 2021;100:100811. [PMID: 33518349 DOI: 10.1016/j.psj.2020.10.065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Zhao L, Wang X, Zhang X, Liu X, Ma N, Zhang Y, Zhang S. Therapeutic strategies for acute intermittent porphyria. Intractable Rare Dis Res 2020;9:205-16. [PMID: 33139979 DOI: 10.5582/irdr.2020.03089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
49 Wang Z, Gao J, Teng H, Peng J. RETRACTED ARTICLE: Role of aminolevulinic acid synthase 1 in doxorubicin-induced oxidative stress to the ardiomyocyte. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:2231-2231. [DOI: 10.1007/s00210-019-01799-9] [Reference Citation Analysis]
50 Ma L, Tian Y, Peng C, Zhang Y, Zhang S. Recent advances in the epidemiology and genetics of acute intermittent porphyria. Intractable Rare Dis Res 2020;9:196-204. [PMID: 33139978 DOI: 10.5582/irdr.2020.03082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
51 Kazamel M, Desnick RJ, Quigley JG. Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management. Curr Neurol Neurosci Rep 2020;20:56. [PMID: 33026560 DOI: 10.1007/s11910-020-01078-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
52 Solares I, Tejedor M, Jericó D, Morales-Conejo M, Enríquez de Salamanca R, Fontanellas A, Tejedor-Jorge A. Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan. Ann Transl Med 2020;8:1098. [PMID: 33145317 DOI: 10.21037/atm-20-1529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
53 Shetty T, Corson TW. Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases. Front Pharmacol 2020;11:1015. [PMID: 32760270 DOI: 10.3389/fphar.2020.01015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
54 Müller S, Perdikari A, Dapito DH, Sun W, Wollscheid B, Balaz M, Wolfrum C. ESRRG and PERM1 Govern Mitochondrial Conversion in Brite/Beige Adipocyte Formation. Front Endocrinol (Lausanne) 2020;11:387. [PMID: 32595605 DOI: 10.3389/fendo.2020.00387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
55 Di Pierro E, Granata F. Nutrients and Porphyria: An Intriguing Crosstalk. Int J Mol Sci 2020;21:E3462. [PMID: 32422947 DOI: 10.3390/ijms21103462] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
56 Kim DH, Park MH, Ha S, Bang EJ, Lee Y, Lee AK, Lee J, Yu BP, Chung HY. Anti-inflammatory action of β-hydroxybutyrate via modulation of PGC-1α and FoxO1, mimicking calorie restriction. Aging (Albany NY) 2019;11:1283-304. [PMID: 30811347 DOI: 10.18632/aging.101838] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
57 La P, Oved JH, Ghiaccio V, Rivella S. Mitochondria Biogenesis Modulates Iron-Sulfur Cluster Synthesis to Increase Cellular Iron Uptake. DNA Cell Biol 2020;39:756-65. [PMID: 32282232 DOI: 10.1089/dna.2019.5123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
58 Berger S, Stattmann M, Cicvaric A, Monje FJ, Coiro P, Hotka M, Ricken G, Hainfellner J, Greber-Platzer S, Yasuda M, Desnick RJ, Pollak DD. Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria. Acta Neuropathol Commun 2020;8:38. [PMID: 32197664 DOI: 10.1186/s40478-020-00910-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Cox TM. The porphyrias. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0231] [Reference Citation Analysis]
60 Swenson SA, Moore CM, Marcero JR, Medlock AE, Reddi AR, Khalimonchuk O. From Synthesis to Utilization: The Ins and Outs of Mitochondrial Heme. Cells 2020;9:E579. [PMID: 32121449 DOI: 10.3390/cells9030579] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
61 Andrejic O, Vucic R, Iric Cupic V, Davidovic G. Hypertensive Crisis in Patients with Acute Intermittent Porphyria. Serbian Journal of Experimental and Clinical Research 2020;0. [DOI: 10.1515/sjecr-2017-0039] [Reference Citation Analysis]
62 Yasuda M, Gan L, Chen B, Yu C, Zhang J, Gama-Sosa MA, Pollak DD, Berger S, Phillips JD, Edelmann W, Desnick RJ. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria. Hum Mol Genet 2019;28:1755-67. [PMID: 30615115 DOI: 10.1093/hmg/ddz003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
63 Kamei Y, Hatazawa Y, Uchitomi R, Yoshimura R, Miura S. Regulation of Skeletal Muscle Function by Amino Acids. Nutrients 2020;12:E261. [PMID: 31963899 DOI: 10.3390/nu12010261] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 17.3] [Reference Citation Analysis]
64 Fiorito V, Chiabrando D, Petrillo S, Bertino F, Tolosano E. The Multifaceted Role of Heme in Cancer. Front Oncol 2019;9:1540. [PMID: 32010627 DOI: 10.3389/fonc.2019.01540] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
65 Wang B, Bissell DM. The acute porphyrias. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease 2020. [DOI: 10.1016/b978-0-12-813955-4.00070-2] [Reference Citation Analysis]
66 Peoc'h K, Nicolas G, Schmitt C, Mirmiran A, Daher R, Lefebvre T, Gouya L, Karim Z, Puy H. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias. Molecular Genetics and Metabolism 2019;128:190-7. [DOI: 10.1016/j.ymgme.2019.01.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
67 Pshenichnikova OS, Goncharova MV, Pustovoit YS, Karpova IV, Surin VL. PILOT RESEARCH OF A GENETIC PREDISPOSITION FOR CLINICAL MANIFESTATIONS OF ACUTE INTERMITTENT PORPHYRIA. Gematologiâ i transfuziologiâ 2019;64:123-137. [DOI: 10.35754/0234-5730-2019-64-2-123-137] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Fu Y, Jia J, Yue L, Yang R, Guo Y, Ni X, Shi T. Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria. Front Pharmacol 2019;10:1018. [PMID: 31572191 DOI: 10.3389/fphar.2019.01018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
69 Suh Y, Gandhi J, Seyam O, Jiang W, Joshi G, Smith NL, Ali Khan S. Neurological and neuropsychiatric manifestations of porphyria. International Journal of Neuroscience 2019;129:1226-33. [DOI: 10.1080/00207454.2019.1655014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
70 McNicholas K, MacGregor MN, Gleadle JM. In order for the light to shine so brightly, the darkness must be present-why do cancers fluoresce with 5-aminolaevulinic acid? Br J Cancer 2019;121:631-9. [PMID: 31406300 DOI: 10.1038/s41416-019-0516-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
71 Fontanellas A, Ávila MA, Anderson KE, Deybach JC. Current and innovative emerging therapies for porphyrias with hepatic involvement. J Hepatol 2019;71:422-33. [PMID: 31102718 DOI: 10.1016/j.jhep.2019.05.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
72 Stölzel U, Doss MO, Schuppan D. Clinical Guide and Update on Porphyrias. Gastroenterology 2019;157:365-381.e4. [PMID: 31085196 DOI: 10.1053/j.gastro.2019.04.050] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 14.8] [Reference Citation Analysis]
73 Badawy AA. Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias. Med Hypotheses 2019;131:109314. [PMID: 31443750 DOI: 10.1016/j.mehy.2019.109314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
74 Anderson KE. Acute hepatic porphyrias: Current diagnosis & management. Mol Genet Metab 2019;128:219-27. [PMID: 31311713 DOI: 10.1016/j.ymgme.2019.07.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
75 Hermann M, Bilandzic L, Stölzel U, Hinkel UP. 29-jährige Patientin mit Syndrom der inadäquaten ADH-Sekretion unklarer Ursache. Nephrologe 2019;14:287-290. [DOI: 10.1007/s11560-019-0345-8] [Reference Citation Analysis]
76 Fader KA, Nault R, Doskey CM, Fling RR, Zacharewski TR. 2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice. Sci Rep 2019;9:6514. [PMID: 31015483 DOI: 10.1038/s41598-019-42760-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
77 Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab 2019;128:164-77. [PMID: 31326287 DOI: 10.1016/j.ymgme.2019.04.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 15.3] [Reference Citation Analysis]
78 Chen B, Wang M, Gan L, Zhang B, Desnick RJ, Yasuda M. Characterization of the hepatic transcriptome following phenobarbital induction in mice with AIP. Mol Genet Metab 2019;128:382-90. [PMID: 30777612 DOI: 10.1016/j.ymgme.2018.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
79 Zhang X, Yang S, Chen J, Su Z. Unraveling the Regulation of Hepatic Gluconeogenesis. Front Endocrinol (Lausanne). 2018;9:802. [PMID: 30733709 DOI: 10.3389/fendo.2018.00802] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 23.8] [Reference Citation Analysis]
80 Brewer CT, Low J, Chen T. High-Throughput Imaging of PPIX Using Confocal Microscopy. Methods Mol Biol 2019;1966:137-49. [PMID: 31041744 DOI: 10.1007/978-1-4939-9195-2_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute Hepatic Porphyrias: Review and Recent Progress. Hepatol Commun 2019;3:193-206. [PMID: 30766957 DOI: 10.1002/hep4.1297] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
82 Storjord E, Dahl JA, Landsem A, Ludviksen JK, Karlsen MB, Karlsen BO, Brekke OL. Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: Results from a case-control study in northern Norway. Mol Genet Metab 2019;128:254-70. [PMID: 30583995 DOI: 10.1016/j.ymgme.2018.12.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
83 Loskove Y, Yasuda M, Chen B, Nazarenko I, Cody N, Desnick RJ. Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations. Mol Genet Metab 2019;128:352-7. [PMID: 30385147 DOI: 10.1016/j.ymgme.2018.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Yien YY, Shi J, Chen C, Cheung JTM, Grillo AS, Shrestha R, Li L, Zhang X, Kafina MD, Kingsley PD, King MJ, Ablain J, Li H, Zon LI, Palis J, Burke MD, Bauer DE, Orkin SH, Koehler CM, Phillips JD, Kaplan J, Ward DM, Lodish HF, Paw BH. FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity. J Biol Chem 2018;293:19797-811. [PMID: 30366982 DOI: 10.1074/jbc.RA118.002742] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
85 Stölzel U, Kubisch I, Stauch T. Porphyrien – was ist gesichert? Internist 2018;59:1239-48. [DOI: 10.1007/s00108-018-0509-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
86 Jiang L, Berraondo P, Jericó D, Guey LT, Sampedro A, Frassetto A, Benenato KE, Burke K, Santamaría E, Alegre M, Pejenaute Á, Kalariya M, Butcher W, Park JS, Zhu X, Sabnis S, Kumarasinghe ES, Salerno T, Kenney M, Lukacs CM, Ávila MA, Martini PGV, Fontanellas A. Systemic messenger RNA as an etiological treatment for acute intermittent porphyria. Nat Med 2018;24:1899-909. [PMID: 30297912 DOI: 10.1038/s41591-018-0199-z] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 18.0] [Reference Citation Analysis]
87 Zhao F, Xiao C, Evans KS, Theivanthiran T, DeVito N, Holtzhausen A, Liu J, Liu X, Boczkowski D, Nair S, Locasale JW, Hanks BA. Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization. Immunity 2018;48:147-160.e7. [PMID: 29343435 DOI: 10.1016/j.immuni.2017.12.004] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 25.0] [Reference Citation Analysis]
88 Kristensen CM, Olsen MA, Jessen H, Brandt N, Meldgaard JN, Pilegaard H. PGC-1α in exercise and fasting-induced regulation of hepatic UPR in mice. Pflugers Arch 2018;470:1431-47. [PMID: 29961149 DOI: 10.1007/s00424-018-2159-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
89 Smith AG, Foster JR. The association between chemical-induced porphyria and hepatic cancer. Toxicol Res (Camb) 2018;7:647-63. [PMID: 30090612 DOI: 10.1039/c8tx00019k] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
90 Edel Y, Mamet R. Porphyria: What Is It and Who Should Be Evaluated? Rambam Maimonides Med J 2018;9. [PMID: 29553924 DOI: 10.5041/RMMJ.10333] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
91 Schmitt C, Lenglet H, Yu A, Delaby C, Benecke A, Lefebvre T, Letteron P, Paradis V, Wahlin S, Sandberg S, Harper P, Sardh E, Sandvik AK, Hov JR, Aarsand AK, Chiche L, Bazille C, Scoazec JY, To-Figueras J, Carrascal M, Abian J, Mirmiran A, Karim Z, Deybach JC, Puy H, Peoc'h K, Manceau H, Gouya L. Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver. J Intern Med 2018;284:78-91. [PMID: 29498764 DOI: 10.1111/joim.12750] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 12.6] [Reference Citation Analysis]
92 Ruspini SF, Zuccoli JR, Lavandera JV, Martínez MDC, Oliveri LM, Gerez EN, Batlle AMDC, Buzaleh AM. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs. Biochim Biophys Acta Gen Subj 2018;1862:1296-305. [PMID: 29476795 DOI: 10.1016/j.bbagen.2018.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
93 Saitoh S, Okano S, Nohara H, Nakano H, Shirasawa N, Naito A, Yamamoto M, Kelly VP, Takahashi K, Tanaka T, Nakajima M, Nakajima O. 5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice. PLoS One 2018;13:e0189593. [PMID: 29364890 DOI: 10.1371/journal.pone.0189593] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
94 Fuller SJ, Wiley JS. Heme Biosynthesis and Its Disorders. Hematology 2018. [DOI: 10.1016/b978-0-323-35762-3.00038-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Júnior VRS, Lemos VMV, Feitosa IML, Florencio R, Correia CWB, Fontes LBC, Costa MFH, Correia MCB. Effect of Menstrual Cycle on Acute Intermittent Porphyria. Child Neurol Open 2017;4:2329048X17736170. [PMID: 29094055 DOI: 10.1177/2329048X17736170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
96 Chang JS, Jun HJ, Park M. Transcriptional coactivator NT-PGC-1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis. Physiol Rep 2016;4:e13013. [PMID: 27798359 DOI: 10.14814/phy2.13013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
97 Cao Y, Song J, Shen S, Fu H, Li X, Xu Y, Wang A, Li X, Zhang M. Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats. Oncotarget 2017;8:92064-78. [PMID: 29190898 DOI: 10.18632/oncotarget.20752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
98 Singh SP, Grant I, Meissner A, Kappas A, Abraham NG. Ablation of adipose-HO-1 expression increases white fat over beige fat through inhibition of mitochondrial fusion and of PGC1α in female mice. Horm Mol Biol Clin Investig 2017;31:/j/hmbci. [PMID: 28763300 DOI: 10.1515/hmbci-2017-0027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
99 Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E. Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury. Clin J Gastroenterol 2017;10:452-8. [PMID: 28676994 DOI: 10.1007/s12328-017-0760-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
100 Jaramillo-calle DA. El grupo hemo y la ácido aminolevulínico sintasa 1 en la fisiopatología de los ataques agudos de porfiria. Revista del Laboratorio Clínico 2017;10:162-170. [DOI: 10.1016/j.labcli.2016.08.003] [Reference Citation Analysis]
101 Conway AJ, Brown FC, Fullinfaw RO, Kile BT, Jane SM, Curtis DJ. A mouse model of hereditary coproporphyria identified in an ENU mutagenesis screen. Dis Model Mech 2017;10:1005-13. [PMID: 28600349 DOI: 10.1242/dmm.029116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 Chung J, Wittig JG, Ghamari A, Maeda M, Dailey TA, Bergonia H, Kafina MD, Coughlin EE, Minogue CE, Hebert AS, Li L, Kaplan J, Lodish HF, Bauer DE, Orkin SH, Cantor AB, Maeda T, Phillips JD, Coon JJ, Pagliarini DJ, Dailey HA, Paw BH. Erythropoietin signaling regulates heme biosynthesis. Elife 2017;6:e24767. [PMID: 28553927 DOI: 10.7554/eLife.24767] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
103 Lei LJ, Guo YH, Yang Y. Recurrent abdominal pain as principal clinical manifestation of acute intermittent porphyria: A case report and literature review. Shijie Huaren Xiaohua Zazhi 2017; 25(12): 1128-1134 [DOI: 10.11569/wcjd.v25.i12.1128] [Reference Citation Analysis]
104 Frison M, Mallach AK, Kennedy E, Campanella M. The 18 kDa Translocator Protein (TSPO): Cholesterol Trafficking and the Biology of a Prognostic and Therapeutic Mitochondrial Target. Molecular Basis for Mitochondrial Signaling 2017. [DOI: 10.1007/978-3-319-55539-3_11] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Stein PE, Badminton MN, Rees DC. Update review of the acute porphyrias. Br J Haematol 2017;176:527-38. [PMID: 27982422 DOI: 10.1111/bjh.14459] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 11.9] [Reference Citation Analysis]
106 Storjord E, Dahl JA, Landsem A, Fure H, Ludviksen JK, Goldbeck-Wood S, Karlsen BO, Berg KS, Mollnes TE, W Nielsen E, Brekke OL. Systemic inflammation in acute intermittent porphyria: a case-control study. Clin Exp Immunol 2017;187:466-79. [PMID: 27859020 DOI: 10.1111/cei.12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
107 Hay SM, McArdle HJ, Hayes HE, Stevens VJ, Rees WD. The effect of iron deficiency on the temporal changes in the expression of genes associated with fat metabolism in the pregnant rat. Physiol Rep 2016;4:e12908. [PMID: 27905292 DOI: 10.14814/phy2.12908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
108 Fontanellas A, Ávila MA, Berraondo P. Emerging therapies for acute intermittent porphyria. Expert Rev Mol Med 2016;18:e17. [PMID: 27804912 DOI: 10.1017/erm.2016.18] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
109 Arora S, Young S, Kodali S, Singal AK. Hepatic porphyria: A narrative review. Indian J Gastroenterol 2016;35:405-18. [PMID: 27796941 DOI: 10.1007/s12664-016-0698-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
110 Moghe A, Phillips JD, Anderson KE. Haeme Biosynthesis. eLS 2016. [DOI: 10.1002/9780470015902.a0000556.pub2] [Reference Citation Analysis]
111 Singh SP, Schragenheim J, Cao J, Falck JR, Abraham NG, Bellner L. PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid. Prostaglandins Other Lipid Mediat 2016;125:8-18. [PMID: 27418542 DOI: 10.1016/j.prostaglandins.2016.07.004] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
112 Waldman M, Bellner L, Vanella L, Schragenheim J, Sodhi K, Singh SP, Lin D, Lakhkar A, Li J, Hochhauser E, Arad M, Darzynkiewicz Z, Kappas A, Abraham NG. Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function. Stem Cells Dev 2016;25:1084-94. [PMID: 27224420 DOI: 10.1089/scd.2016.0072] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
113 Rey G, Reddy AB. Interplay between cellular redox oscillations and circadian clocks. Diabetes Obes Metab 2015;17 Suppl 1:55-64. [PMID: 26332969 DOI: 10.1111/dom.12519] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
114 Stubenhaus BM, Dustin JP, Neverett ER, Beaudry MS, Nadeau LE, Burk-McCoy E, He X, Pearson BJ, Pellettieri J. Light-induced depigmentation in planarians models the pathophysiology of acute porphyrias. Elife 2016;5:e14175. [PMID: 27240733 DOI: 10.7554/eLife.14175] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
115 Distante S, Eikeland J, Pawar T, Skinnes R, Høie K, You P, Mørkrid L, Eide L. Blood removal therapy in hereditary hemochromatosis induces a stress response resulting in improved genome integrity. Transfusion 2016;56:1435-41. [PMID: 27045387 DOI: 10.1111/trf.13588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
116 New GH, Hsu P, Wu M. Acute intermittent porphyria exacerbation following in vitro fertilization treatment. Taiwanese Journal of Obstetrics and Gynecology 2016;55:281-4. [DOI: 10.1016/j.tjog.2015.08.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
117 Peoc'h K, Martin-Schmitt C, Talbi N, Deybach JC, Gouya L, Puy H. [Porphyrias and haem related disorders]. Rev Med Interne 2016;37:173-85. [PMID: 26774916 DOI: 10.1016/j.revmed.2015.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
118 Collantes M, Serrano-Mendioroz I, Benito M, Molinet-Dronda F, Delgado M, Vinaixa M, Sampedro A, Enríquez de Salamanca R, Prieto E, Pozo MA, Peñuelas I, Corrales FJ, Barajas M, Fontanellas A. Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency. Hum Mol Genet 2016;25:1318-27. [PMID: 26908609 DOI: 10.1093/hmg/ddw013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
119 Barupala DP, Dzul SP, Riggs-Gelasco PJ, Stemmler TL. Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors. Arch Biochem Biophys 2016;592:60-75. [PMID: 26785297 DOI: 10.1016/j.abb.2016.01.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
120 Sarosiek K, Pappan KL, Gandhi AV, Saxena S, Kang CY, McMahon H, Chipitsyna GI, Tichansky DS, Arafat HA. Conserved Metabolic Changes in Nondiabetic and Type 2 Diabetic Bariatric Surgery Patients: Global Metabolomic Pilot Study. J Diabetes Res 2016;2016:3467403. [PMID: 26881244 DOI: 10.1155/2016/3467403] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
121 Carter EL, Gupta N, Ragsdale SW. High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erbβ Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor. J Biol Chem 2016;291:2196-222. [PMID: 26670607 DOI: 10.1074/jbc.M115.670281] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
122 Sachar M, Anderson KE, Ma X. Protoporphyrin IX: the Good, the Bad, and the Ugly. J Pharmacol Exp Ther 2016;356:267-75. [PMID: 26588930 DOI: 10.1124/jpet.115.228130] [Cited by in Crossref: 108] [Cited by in F6Publishing: 113] [Article Influence: 13.5] [Reference Citation Analysis]
123 Kupr B, Handschin C. Complex Coordination of Cell Plasticity by a PGC-1α-controlled Transcriptional Network in Skeletal Muscle. Front Physiol 2015;6:325. [PMID: 26617528 DOI: 10.3389/fphys.2015.00325] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
124 Chan A, Liebow A, Yasuda M, Gan L, Racie T, Maier M, Kuchimanchi S, Foster D, Milstein S, Charisse K, Sehgal A, Manoharan M, Meyers R, Fitzgerald K, Simon A, Desnick RJ, Querbes W. Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification. Mol Ther Nucleic Acids 2015;4:e263. [PMID: 26528940 DOI: 10.1038/mtna.2015.36] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 11.4] [Reference Citation Analysis]
125 Herrero C, Badenas C, Aguilera P, To-figueras J. Acute intermittent porphyria: Long-term follow up of 35 patients. Medicina Clínica (English Edition) 2015;145:332-337. [DOI: 10.1016/j.medcle.2016.02.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Herrero C, Badenas C, Aguilera P, To-figueras J. Porfiria aguda intermitente: seguimiento a largo término de 35 pacientes. Medicina Clínica 2015;145:332-7. [DOI: 10.1016/j.medcli.2014.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
127 Karim Z, Lyoumi S, Nicolas G, Deybach JC, Gouya L, Puy H. Porphyrias: A 2015 update. Clin Res Hepatol Gastroenterol 2015;39:412-25. [PMID: 26142871 DOI: 10.1016/j.clinre.2015.05.009] [Cited by in Crossref: 107] [Cited by in F6Publishing: 107] [Article Influence: 13.4] [Reference Citation Analysis]
128 Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet. 2015;8:201-214. [PMID: 26366103 DOI: 10.2147/tacg.s48605] [Cited by in Crossref: 105] [Cited by in F6Publishing: 114] [Article Influence: 13.1] [Reference Citation Analysis]
129 Gut P. Targeting mitochondrial energy metabolism with TSPO ligands. Biochem Soc Trans 2015;43:537-42. [PMID: 26551690 DOI: 10.1042/BST20150019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
130 Huss JM, Garbacz WG, Xie W. Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease. Biochim Biophys Acta 2015;1852:1912-27. [PMID: 26115970 DOI: 10.1016/j.bbadis.2015.06.016] [Cited by in Crossref: 106] [Cited by in F6Publishing: 114] [Article Influence: 13.3] [Reference Citation Analysis]
131 Mizutani T, Kawabe S, Ishikane S, Imamichi Y, Umezawa A, Miyamoto K. Identification of novel steroidogenic factor 1 (SF-1)-target genes and components of the SF-1 nuclear complex. Molecular and Cellular Endocrinology 2015;408:133-7. [DOI: 10.1016/j.mce.2014.11.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
132 Gut P, Zweckstetter M, Banati RB. Lost in translocation: the functions of the 18-kD translocator protein. Trends Endocrinol Metab 2015;26:349-56. [PMID: 26026242 DOI: 10.1016/j.tem.2015.04.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
133 Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66:948-83. [PMID: 25073467 DOI: 10.1124/pr.113.008201] [Cited by in Crossref: 510] [Cited by in F6Publishing: 527] [Article Influence: 63.8] [Reference Citation Analysis]
134 Roveri G, Nascimbeni F, Rocchi E, Ventura P. Drugs and acute porphyrias: reasons for a hazardous relationship. Postgrad Med 2014;126:108-20. [PMID: 25387219 DOI: 10.3810/pgm.2014.11.2839] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
135 Philip M, Funkhouser SA, Chiu EY, Phelps SR, Delrow JJ, Cox J, Fink PJ, Abkowitz JL. Heme exporter FLVCR is required for T cell development and peripheral survival. J Immunol 2015;194:1677-85. [PMID: 25582857 DOI: 10.4049/jimmunol.1402172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
136 Badawy AA. Tryptophan Metabolism and the Hepatic Kynurenine Pathway in Health and Disease. In: Mittal S, editor. Targeting the Broadly Pathogenic Kynurenine Pathway. Cham: Springer International Publishing; 2015. pp. 11-30. [DOI: 10.1007/978-3-319-11870-3_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
137 Vágány V, Smith AG. Complicity of haem in some adverse drug-reactions. Toxicol Res 2015;4:1128-1142. [DOI: 10.1039/c5tx00011d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Stölzel U, Stauch T, Lindner U, Doss MO. Intensivtherapie bei akuten Porphyrien. Die Intensivmedizin 2015. [DOI: 10.1007/978-3-642-54675-4_80-1] [Reference Citation Analysis]
139 Doss MO, Lindner U, Stölzel U, Stauch T. Akute Porphyrien. Die Intensivmedizin 2015. [DOI: 10.1007/978-3-642-54953-3_69] [Reference Citation Analysis]
140 Stremmel W, Merle U, Stölzel U, Doss MO. Genetisch bedingte Stoffwechselerkrankungen des Gastrointestinaltrakts. Viszeralmedizin 2015. [DOI: 10.1007/978-3-642-14301-4_41] [Reference Citation Analysis]
141 Montgomery Bissell D. The Porphyrias. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Elsevier; 2015. pp. 731-49. [DOI: 10.1016/b978-0-12-410529-4.00066-8] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
142 Sun C, Wang M, Liu X, Luo L, Li K, Zhang S, Wang Y, Yang Y, Ding F, Gu X. PCAF improves glucose homeostasis by suppressing the gluconeogenic activity of PGC-1α. Cell Rep 2014;9:2250-62. [PMID: 25497092 DOI: 10.1016/j.celrep.2014.11.029] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
143 Besur S, Hou W, Schmeltzer P, Bonkovsky HL. Clinically important features of porphyrin and heme metabolism and the porphyrias. Metabolites. 2014;4:977-1006. [PMID: 25372274 DOI: 10.3390/metabo4040977] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 7.7] [Reference Citation Analysis]
144 Simcox JA, Mitchell TC, Gao Y, Just SF, Cooksey R, Cox J, Ajioka R, Jones D, Lee SH, King D, Huang J, McClain DA. Dietary iron controls circadian hepatic glucose metabolism through heme synthesis. Diabetes 2015;64:1108-19. [PMID: 25315005 DOI: 10.2337/db14-0646] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
145 Bailey SM, Udoh US, Young ME. Circadian regulation of metabolism. J Endocrinol 2014;222:R75-96. [PMID: 24928941 DOI: 10.1530/JOE-14-0200] [Cited by in Crossref: 142] [Cited by in F6Publishing: 147] [Article Influence: 15.8] [Reference Citation Analysis]
146 Urasaki Y, Pizzorno G, Le TT. Uridine affects liver protein glycosylation, insulin signaling, and heme biosynthesis. PLoS One 2014;9:e99728. [PMID: 24918436 DOI: 10.1371/journal.pone.0099728] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
147 Homedan C, Laafi J, Schmitt C, Gueguen N, Lefebvre T, Karim Z, Desquiret-dumas V, Wetterwald C, Deybach J, Gouya L, Puy H, Reynier P, Malthièry Y. Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model. The International Journal of Biochemistry & Cell Biology 2014;51:93-101. [DOI: 10.1016/j.biocel.2014.03.032] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
148 Puy H, Gouya L, Deybach J. Les porphyries héréditaires : anomalies du métabolisme de l’hème. Bulletin de l'Académie Nationale de Médecine 2014;198:1069-1093. [DOI: 10.1016/s0001-4079(19)31260-9] [Reference Citation Analysis]
149 Yasuda M, Gan L, Chen B, Kadirvel S, Yu C, Phillips JD, New MI, Liebow A, Fitzgerald K, Querbes W, Desnick RJ. RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice. Proc Natl Acad Sci U S A 2014;111:7777-82. [PMID: 24821812 DOI: 10.1073/pnas.1406228111] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 9.6] [Reference Citation Analysis]
150 Harper P, Sardh E. Management of acute intermittent porphyria. Expert Opinion on Orphan Drugs 2014;2:349-68. [DOI: 10.1517/21678707.2014.891456] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
151 Desnick RJ, Balwani M, Anderson KE. Heme biosynthesis and the porphyrias. Liver Disease in Children 2014. [DOI: 10.1017/cbo9781139012102.031] [Reference Citation Analysis]
152 Laudet V. Nuclear receptors: at the heart of the biological crosstalk between metabolism and circadian rhythm. Expert Rev Endocrinol Metab 2008;3:411-4. [PMID: 30290430 DOI: 10.1586/17446651.3.4.411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Stölzel U, Stauch T, Doss M. Akute Porphyrien. Angeborene Stoffwechselkrankheiten bei Erwachsenen 2014. [DOI: 10.1007/978-3-642-45188-1_50] [Reference Citation Analysis]
154 Stölzel U, Stauch T, Doss MO. Heme Synthesis Defects and Porphyrias. Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases 2014. [DOI: 10.1007/978-3-642-40337-8_33] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
155 Anderson KE. Porphyrias: Acute Manifestations. Endocrine Emergencies 2014. [DOI: 10.1007/978-1-62703-697-9_20] [Reference Citation Analysis]
156 Eisele PS, Handschin C. Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology. Semin Immunopathol 2014;36:27-53. [DOI: 10.1007/s00281-013-0406-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
157 Stein P, Badminton M, Barth J, Rees D, Stewart MF; British and Irish Porphyria Network. Best practice guidelines on clinical management of acute attacks of porphyria and their complications. Ann Clin Biochem 2013;50:217-23. [PMID: 23605132 DOI: 10.1177/0004563212474555] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
158 Jiang Z, Cowell RM, Nakazawa K. Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia. Front Behav Neurosci 2013;7:116. [PMID: 24027504 DOI: 10.3389/fnbeh.2013.00116] [Cited by in Crossref: 50] [Cited by in F6Publishing: 62] [Article Influence: 5.0] [Reference Citation Analysis]
159 Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab. 2013;17:329-341. [PMID: 23473030 DOI: 10.1016/j.cmet.2013.02.007] [Cited by in Crossref: 284] [Cited by in F6Publishing: 254] [Article Influence: 28.4] [Reference Citation Analysis]
160 Kluge MA, Fetterman JL, Vita JA. Mitochondria and endothelial function. Circ Res 2013;112:1171-88. [PMID: 23580773 DOI: 10.1161/CIRCRESAHA.111.300233] [Cited by in Crossref: 300] [Cited by in F6Publishing: 309] [Article Influence: 30.0] [Reference Citation Analysis]
161 Jeong HS. Efficacy of Alismatis Orientale Rhizoma on Obesity induced by High Fat Diet. The Korea Journal of Herbology 2013;28:95-106. [DOI: 10.6116/kjh.2013.28.3.95] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
162 Xiong S, Salazar G, Patrushev N, Ma M, Forouzandeh F, Hilenski L, Alexander RW. Peroxisome proliferator-activated receptor γ coactivator-1α is a central negative regulator of vascular senescence. Arterioscler Thromb Vasc Biol 2013;33:988-98. [PMID: 23430617 DOI: 10.1161/ATVBAHA.112.301019] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
163 Charos AE, Reed BD, Raha D, Szekely AM, Weissman SM, Snyder M. A highly integrated and complex PPARGC1A transcription factor binding network in HepG2 cells. Genome Res 2012;22:1668-79. [PMID: 22955979 DOI: 10.1101/gr.127761.111] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
164 Bonkovsky HL, Guo J, Hou W, Li T, Narang T, Thapar M. Porphyrin and Heme Metabolism and the Porphyrias. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 365-401. [DOI: 10.1002/cphy.c120006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 99] [Article Influence: 8.5] [Reference Citation Analysis]
165 Desnick R, Balwani M, Anderson KE. Inherited Porphyrias. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00104-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
166 Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Hematology 2012;2012:19-27. [DOI: 10.1182/asheducation.v2012.1.19.3795678] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
167 Rees DC. The acute porphyrias. Clin Med 2012;12:s37-40. [DOI: 10.7861/clinmedicine.12-6-s37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
168 Danion F, Guillot M, Castelain V, Puy H, Deybach J, Schneider F. An Uncommon Option for Surviving Bariatric Surgery: Regaining Weight! The American Journal of Medicine 2012;125:e1-2. [DOI: 10.1016/j.amjmed.2012.01.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
169 Ju Y, Mizutani T, Imamichi Y, Yazawa T, Matsumura T, Kawabe S, Kanno M, Umezawa A, Kangawa K, Miyamoto K. Nuclear receptor 5A (NR5A) family regulates 5-aminolevulinic acid synthase 1 (ALAS1) gene expression in steroidogenic cells. Endocrinology. 2012;153:5522-5534. [PMID: 23024262 DOI: 10.1210/en.2012-1334] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
170 Uddin MJ, Joe Y, Zheng M, Kim S, Lee H, Kwon TO, Chung HT. Inhibitory Effects of Chung Hun Wha Dam Tang (CHWDT) on High-Fat Diet-Induced Obesity via AMP-Activated Protein Kinase Activation. Evid Based Complement Alternat Med 2012;2012:652473. [PMID: 22973402 DOI: 10.1155/2012/652473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
171 Stein PE, Badminton MN, Barth JH, Rees DC, Sarkany R, Stewart MF, Cox TM. Acute intermittent porphyria: fatal complications of treatment. Clin Med (Lond) 2012;12:293-4. [PMID: 22783787 DOI: 10.7861/clinmedicine.12-3-293] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
172 Lämsä V, Levonen AL, Sormunen R, Yamamoto M, Hakkola J. Heme and heme biosynthesis intermediates induce heme oxygenase-1 and cytochrome P450 2A5, enzymes with putative sequential roles in heme and bilirubin metabolism: different requirement for transcription factor nuclear factor erythroid- derived 2-like 2. Toxicol Sci 2012;130:132-44. [PMID: 22859313 DOI: 10.1093/toxsci/kfs237] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
173 Hasenour CM, Berglund ED, Wasserman DH. Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver. Mol Cell Endocrinol 2013;366:152-62. [PMID: 22796337 DOI: 10.1016/j.mce.2012.06.018] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 5.6] [Reference Citation Analysis]
174 Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood 2012;120:4496-504. [PMID: 22791288 DOI: 10.1182/blood-2012-05-423186] [Cited by in Crossref: 153] [Cited by in F6Publishing: 158] [Article Influence: 13.9] [Reference Citation Analysis]
175 Iwadate R, Satoh Y, Watanabe Y, Kawai H, Kudo N, Kawashima Y, Mashino T, Mitsumoto A. Impairment of heme biosynthesis induces short circadian period in body temperature rhythms in mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2012;303:R8-R18. [DOI: 10.1152/ajpregu.00019.2011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
176 Degli Esposti D, Hamelin J, Bosselut N, Saffroy R, Sebagh M, Pommier A, Martel C, Lemoine A. Mitochondrial roles and cytoprotection in chronic liver injury. Biochem Res Int 2012;2012:387626. [PMID: 22745910 DOI: 10.1155/2012/387626] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 7.3] [Reference Citation Analysis]
177 García-Diz L, Murcia MA, Gris JL, Pons A, Monteagudo C, Martínez-Tomé M, Jiménez-Monreal AM. Assessing nutritional status of acute intermittent porphyria patients. Eur J Clin Invest 2012;42:943-52. [PMID: 22519672 DOI: 10.1111/j.1365-2362.2012.02673.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
178 Oliveri LM, Davio C, Batlle AM, Gerez EN. ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice. Biochem J 2012;442:303-10. [PMID: 22070747 DOI: 10.1042/BJ20111005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
179 Molusky MM, Li S, Ma D, Yu L, Lin JD. Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1. Diabetes 2012;61:1025-35. [PMID: 22447855 DOI: 10.2337/db11-0970] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
180 Zmrzljak UP, Rozman D. Circadian regulation of the hepatic endobiotic and xenobitoic detoxification pathways: the time matters. Chem Res Toxicol 2012;25:811-24. [PMID: 22303888 DOI: 10.1021/tx200538r] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 5.7] [Reference Citation Analysis]
181 Delezie J, Challet E. Interactions between metabolism and circadian clocks: reciprocal disturbances. Ann N Y Acad Sci. 2011;1243:30-46. [PMID: 22211891 DOI: 10.1111/j.1749-6632.2011.06246.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 7.6] [Reference Citation Analysis]
182 Egger A, Samardzija M, Sothilingam V, Tanimoto N, Lange C, Salatino S, Fang L, Garcia-Garrido M, Beck S, Okoniewski MJ, Neutzner A, Seeliger MW, Grimm C, Handschin C. PGC-1α determines light damage susceptibility of the murine retina. PLoS One 2012;7:e31272. [PMID: 22348062 DOI: 10.1371/journal.pone.0031272] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
183 Jitrapakdee S. Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. The International Journal of Biochemistry & Cell Biology 2012;44:33-45. [DOI: 10.1016/j.biocel.2011.10.001] [Cited by in Crossref: 127] [Cited by in F6Publishing: 130] [Article Influence: 11.5] [Reference Citation Analysis]
184 Badminton MN, Whatley SD, Deacon AC, Elder GH. The Porphyrias and Other Disorders of Porphyrin Metabolism. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 2012. [DOI: 10.1016/b978-1-4160-6164-9.00033-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
185 Sahar S, Sassone-Corsi P. Regulation of metabolism: the circadian clock dictates the time. Trends Endocrinol Metab 2012;23:1-8. [PMID: 22169754 DOI: 10.1016/j.tem.2011.10.005] [Cited by in Crossref: 142] [Cited by in F6Publishing: 147] [Article Influence: 11.8] [Reference Citation Analysis]
186 Venkatesh S, Lee J, Singh K, Lee I, Suzuki CK. Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta 2012;1823:56-66. [PMID: 22119779 DOI: 10.1016/j.bbamcr.2011.11.003] [Cited by in Crossref: 122] [Cited by in F6Publishing: 127] [Article Influence: 10.2] [Reference Citation Analysis]
187 Li S, Chen XW, Yu L, Saltiel AR, Lin JD. Circadian metabolic regulation through crosstalk between casein kinase 1δ and transcriptional coactivator PGC-1α. Mol Endocrinol 2011;25:2084-93. [PMID: 22052997 DOI: 10.1210/me.2011-1227] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
188 Hift RJ, Thunell S, Brun A. Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity. Pharmacology & Therapeutics 2011;132:158-69. [DOI: 10.1016/j.pharmthera.2011.06.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
189 Haase TN, Ringholm S, Leick L, Biensø RS, Kiilerich K, Johansen S, Nielsen MM, Wojtaszewski JF, Hidalgo J, Pedersen PA, Pilegaard H. Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2011;301:R1501-9. [DOI: 10.1152/ajpregu.00775.2010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
190 Jones AW, Yao Z, Vicencio JM, Karkucinska-Wieckowska A, Szabadkai G. PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling. Mitochondrion. 2012;12:86-99. [PMID: 21983689 DOI: 10.1016/j.mito.2011.09.009] [Cited by in Crossref: 93] [Cited by in F6Publishing: 100] [Article Influence: 7.8] [Reference Citation Analysis]
191 Schmidt SF, Mandrup S. Gene program-specific regulation of PGC-1{alpha} activity. Genes Dev 2011;25:1453-8. [PMID: 21764849 DOI: 10.1101/gad.2076411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
192 Tian Q, Li T, Hou W, Zheng J, Schrum LW, Bonkovsky HL. Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells. J Biol Chem. 2011;286:26424-26430. [PMID: 21659532 DOI: 10.1074/jbc.m110.215772] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 7.4] [Reference Citation Analysis]
193 Lustig Y, Ruas JL, Estall JL, Lo JC, Devarakonda S, Laznik D, Choi JH, Ono H, Olsen JV, Spiegelman BM. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. Genes Dev 2011;25:1232-44. [PMID: 21646374 DOI: 10.1101/gad.2054711] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
194 Gotoh S, Nakamura T, Kataoka T, Taketani S. Egr-1 regulates the transcriptional repression of mouse δ-aminolevulinic acid synthase 1 by heme. Gene 2011;472:28-36. [DOI: 10.1016/j.gene.2010.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
195 Amigo JD, Yu M, Troadec MB, Gwynn B, Cooney JD, Lambert AJ, Chi NC, Weiss MJ, Peters LL, Kaplan J, Cantor AB, Paw BH. Identification of distal cis-regulatory elements at mouse mitoferrin loci using zebrafish transgenesis. Mol Cell Biol 2011;31:1344-56. [PMID: 21248200 DOI: 10.1128/MCB.01010-10] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
196 Pischik E, Kauppinen R. Potential Role of Oxidative Damage in Neurological Manifestations of Acute Intermittent Porphyria. Oxidative Stress and Free Radical Damage in Neurology 2011. [DOI: 10.1007/978-1-60327-514-9_16] [Reference Citation Analysis]
197 Stölzel U, Stauch T, Doss M. Porphyrien. Internist 2010;51:1525-34. [DOI: 10.1007/s00108-010-2751-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 2011;120 Suppl 1:S49-75. [PMID: 21059794 DOI: 10.1093/toxsci/kfq338] [Cited by in Crossref: 228] [Cited by in F6Publishing: 240] [Article Influence: 17.5] [Reference Citation Analysis]
199 Schupp M, Lazar MA. Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem 2010;285:40409-15. [PMID: 20956526 DOI: 10.1074/jbc.R110.182451] [Cited by in Crossref: 129] [Cited by in F6Publishing: 130] [Article Influence: 9.9] [Reference Citation Analysis]
200 Ma D, Li S, Lucas EK, Cowell RM, Lin JD. Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions. J Biol Chem 2010;285:39087-95. [PMID: 20947495 DOI: 10.1074/jbc.M110.151688] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
201 Shao D, Liu Y, Liu X, Zhu L, Cui Y, Cui A, Qiao A, Kong X, Liu Y, Chen Q, Gupta N, Fang F, Chang Y. PGC-1β-Regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERRα. Mitochondrion 2010;10:516-27. [DOI: 10.1016/j.mito.2010.05.012] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 7.3] [Reference Citation Analysis]
202 Dwyer BE, Stone ML, Zhu X, Perry G, Smith MA. Heme deficiency in Alzheimer's disease: a possible connection to porphyria. J Biomed Biotechnol 2006;2006:24038. [PMID: 17047301 DOI: 10.1155/JBB/2006/24038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
203 Kumar N, Solt LA, Wang Y, Rogers PM, Bhattacharyya G, Kamenecka TM, Stayrook KR, Crumbley C, Floyd ZE, Gimble JM, Griffin PR, Burris TP. Regulation of adipogenesis by natural and synthetic REV-ERB ligands. Endocrinology 2010;151:3015-25. [PMID: 20427485 DOI: 10.1210/en.2009-0800] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 7.6] [Reference Citation Analysis]
204 Chen BC, Griffey RT. A case report of porphyria variegata management in the emergency department. J Emerg Med 2012;43:e235-8. [PMID: 20417053 DOI: 10.1016/j.jemermed.2010.02.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
205 Yin L, Wu N, Lazar MA. Nuclear receptor Rev-erbalpha: a heme receptor that coordinates circadian rhythm and metabolism. Nucl Recept Signal. 2010;8:e001. [PMID: 20414452 DOI: 10.1621/nrs.08001] [Cited by in Crossref: 82] [Cited by in F6Publishing: 108] [Article Influence: 6.3] [Reference Citation Analysis]
206 Reiser M, Eickmann S, Haverkamp T, Finckh U. Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. Obesity Reviews 2010;11:329-331. [DOI: 10.1111/j.1467-789x.2009.00670.x] [Reference Citation Analysis]
207 Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010;375:924-937. [PMID: 20226990 DOI: 10.1016/s0140-6736(09)61925-5] [Cited by in Crossref: 510] [Cited by in F6Publishing: 525] [Article Influence: 39.2] [Reference Citation Analysis]
208 Handschin C. Regulation of skeletal muscle cell plasticity by the peroxisome proliferator-activated receptor γ coactivator 1α. Journal of Receptors and Signal Transduction 2010;30:376-84. [DOI: 10.3109/10799891003641074] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
209 Ramadori G, Coppari R. Pharmacological manipulations of CNS sirtuins: potential effects on metabolic homeostasis. Pharmacol Res 2010;62:48-54. [PMID: 20138996 DOI: 10.1016/j.phrs.2010.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
210 Le Lay J, Kaestner KH. The Fox genes in the liver: from organogenesis to functional integration. Physiol Rev. 2010;90:1-22. [PMID: 20086072 DOI: 10.1152/physrev.00018.2009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 5.5] [Reference Citation Analysis]
211 Stölzel U, Doss MO. Porphyrias. Clinical Hepatology 2010. [DOI: 10.1007/978-3-642-04519-6_30] [Reference Citation Analysis]
212 Estall JL, Ruas JL, Choi CS, Laznik D, Badman M, Maratos-Flier E, Shulman GI, Spiegelman BM. PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis. Proc Natl Acad Sci U S A 2009;106:22510-5. [PMID: 20018698 DOI: 10.1073/pnas.0912533106] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 6.7] [Reference Citation Analysis]
213 Cerrada-Gimenez M, Häyrinen J, Juutinen S, Reponen T, Jänne J, Alhonen L. Proteomic analysis of livers from a transgenic mouse line with activated polyamine catabolism. Amino Acids 2010;38:613-22. [PMID: 20012117 DOI: 10.1007/s00726-009-0420-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
214 Xiong S, Salazar G, San Martin A, Ahmad M, Patrushev N, Hilenski L, Nazarewicz RR, Ma M, Ushio-Fukai M, Alexander RW. PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. J Biol Chem 2010;285:2474-87. [PMID: 19940161 DOI: 10.1074/jbc.M109.065235] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 4.7] [Reference Citation Analysis]
215 Bonkovsky HL. Neurovisceral porphyrias: what a hematologist needs to know. Hematology Am Soc Hematol Educ Program 2005;:24-30. [PMID: 16304355 DOI: 10.1182/asheducation-2005.1.24] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
216 Delaby C, To-figueras J, Deybach JC, Casamitjana R, Puy H, Herrero C. Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients. Journal of Internal Medicine 2009;266:277-85. [DOI: 10.1111/j.1365-2796.2009.02118.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
217 Wu N, Yin L, Hanniman EA, Joshi S, Lazar MA. Negative feedback maintenance of heme homeostasis by its receptor, Rev-erbalpha. Genes Dev 2009;23:2201-9. [PMID: 19710360 DOI: 10.1101/gad.1825809] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.0] [Reference Citation Analysis]
218 Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA, Burgess SC. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 2009;106:10853-8. [PMID: 19541642 DOI: 10.1073/pnas.0904187106] [Cited by in Crossref: 506] [Cited by in F6Publishing: 519] [Article Influence: 36.1] [Reference Citation Analysis]
219 Ventura P, Cappellini MD, Rocchi E. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. Intern Emerg Med 2009;4:297-308. [DOI: 10.1007/s11739-009-0261-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
220 Dwyer BE, Smith MA, Richardson SL, Perry G, Zhu X. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease. Neurosci Lett 2009;460:180-4. [PMID: 19477221 DOI: 10.1016/j.neulet.2009.05.058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
221 Handschin C. The biology of PGC-1α and its therapeutic potential. Trends Pharmacol Sci 2009;30:322-9. [PMID: 19446346 DOI: 10.1016/j.tips.2009.03.006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
222 Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression. Diabetes 2009;58:1499-508. [PMID: 19366863 DOI: 10.2337/db08-1571] [Cited by in Crossref: 114] [Cited by in F6Publishing: 117] [Article Influence: 8.1] [Reference Citation Analysis]
223 Coppari R, Ramadori G, Elmquist JK. The role of trans-criptional regulators in central control of appetite and body weight. Nat Clin Pract Endocrinol Metab. 2009;5:160-166. [PMID: 19229236 DOI: 10.1038/ncpendmet1070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
224 Sardh E, Harper P, Andersson DE, Floderus Y. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. European Journal of Internal Medicine 2009;20:201-7. [DOI: 10.1016/j.ejim.2008.06.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
225 Li S, Arning E, Liu C, Vitvitsky V, Hernandez C, Banerjee R, Bottiglieri T, Lin JD. Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha. Am J Physiol Endocrinol Metab 2009;296:E543-8. [PMID: 19158324 DOI: 10.1152/ajpendo.90719.2008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
226 Arnold W. Porphyria: Acute Intermittent. Encyclopedia of Neuroscience 2009. [DOI: 10.1016/b978-008045046-9.00604-5] [Reference Citation Analysis]
227 Smith A. Novel Heme-Protein Interactions— Some More Radical Than Others. Tetrapyrroles 2009. [DOI: 10.1007/978-0-387-78518-9_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
228 Lin JD. Minireview: the PGC-1 coactivator networks: chromatin-remodeling and mitochondrial energy metabolism. Mol Endocrinol 2009;23:2-10. [PMID: 19008463 DOI: 10.1210/me.2008-0344] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 5.4] [Reference Citation Analysis]
229 Chernova T, Higginson FM, Davies R, Smith AG. B2 SINE retrotransposon causes polymorphic expression of mouse 5-aminolevulinic acid synthase 1 gene. Biochem Biophys Res Commun 2008;377:515-20. [PMID: 18929534 DOI: 10.1016/j.bbrc.2008.10.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
230 Li S, Liu C, Li N, Hao T, Han T, Hill DE, Vidal M, Lin JD. Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab 2008;8:105-17. [PMID: 18680712 DOI: 10.1016/j.cmet.2008.06.013] [Cited by in Crossref: 125] [Cited by in F6Publishing: 131] [Article Influence: 8.3] [Reference Citation Analysis]
231 Zheng J, Shan Y, Lambrecht RW, Donohue SE, Bonkovsky HL. Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin. Mol Cell Biochem 2008;319:153-61. [PMID: 18719978 DOI: 10.1007/s11010-008-9888-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
232 Handschin C. Induction of Drug Metabolism: Role for Nuclear Receptors. Methods and Principles in Medicinal Chemistry 2008. [DOI: 10.1002/9783527623297.ch15] [Reference Citation Analysis]
233 Nakao A, Faleo G, Shimizu H, Nakahira K, Kohmoto J, Sugimoto R, Choi AM, McCurry KR, Takahashi T, Murase N. Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts. Kidney Int 2008;74:1009-16. [PMID: 18633343 DOI: 10.1038/ki.2008.342] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 4.3] [Reference Citation Analysis]
234 Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008;88:611-638. [PMID: 18391175 DOI: 10.1152/physrev.00025.2007] [Cited by in Crossref: 1060] [Cited by in F6Publishing: 1107] [Article Influence: 70.7] [Reference Citation Analysis]
235 Schilling MM, Oeser JK, Chandy JK, Flemming BP, Allen SR, O'Brien RM. Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha. Diabetologia 2008;51:1505-14. [PMID: 18563384 DOI: 10.1007/s00125-008-1050-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
236 Arpiainen S, Järvenpää SM, Manninen A, Viitala P, Lang MA, Pelkonen O, Hakkola J. Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes. Toxicol Appl Pharmacol 2008;232:135-41. [PMID: 18602936 DOI: 10.1016/j.taap.2008.06.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
237 Dooley KA, Fraenkel PG, Langer NB, Schmid B, Davidson AJ, Weber G, Chiang K, Foott H, Dwyer C, Wingert RA, Zhou Y, Paw BH, Zon LI; Tübingen 2000 Screen Consortium. montalcino, A zebrafish model for variegate porphyria. Exp Hematol 2008;36:1132-42. [PMID: 18550261 DOI: 10.1016/j.exphem.2008.04.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
238 Wang H, Peiris TH, Mowery A, Le Lay J, Gao Y, Greenbaum LE. CCAAT/enhancer binding protein-beta is a transcriptional regulator of peroxisome-proliferator-activated receptor-gamma coactivator-1alpha in the regenerating liver. Mol Endocrinol 2008;22:1596-605. [PMID: 18467525 DOI: 10.1210/me.2007-0388] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
239 Handschin C, Choi CS, Chin S, Kim S, Kawamori D, Kurpad AJ, Neubauer N, Hu J, Mootha VK, Kim YB, Kulkarni RN, Shulman GI, Spiegelman BM. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest 2007;117:3463-74. [PMID: 17932564 DOI: 10.1172/JCI31785] [Cited by in Crossref: 265] [Cited by in F6Publishing: 272] [Article Influence: 17.7] [Reference Citation Analysis]
240 Rogers PM, Ying L, Burris TP. Relationship between circadian oscillations of Rev-erbalpha expression and intracellular levels of its ligand, heme. Biochem Biophys Res Commun 2008;368:955-8. [PMID: 18280802 DOI: 10.1016/j.bbrc.2008.02.031] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
241 Burris TP. Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. Mol Endocrinol. 2008;22:1509-1520. [PMID: 18218725 DOI: 10.1210/me.2007-0519] [Cited by in Crossref: 111] [Cited by in F6Publishing: 119] [Article Influence: 7.4] [Reference Citation Analysis]
242 Meyer UA, Peyer A. Porphyrias. Falk Symposium. [DOI: 10.1007/978-1-4020-6393-0_11] [Reference Citation Analysis]
243 Peyer AK, Jung D, Beer M, Gnerre C, Keogh A, Stroka D, Zavolan M, Meyer UA. Regulation of human liver delta-aminolevulinic acid synthase by bile acids. Hepatology 2007;46:1960-70. [PMID: 17975826 DOI: 10.1002/hep.21879] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
244 Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, Burris LL, Khorasanizadeh S, Burris TP, Rastinejad F. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol 2007;14:1207-13. [PMID: 18037887 DOI: 10.1038/nsmb1344] [Cited by in Crossref: 419] [Cited by in F6Publishing: 436] [Article Influence: 26.2] [Reference Citation Analysis]
245 Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, Waitt GM, Parks DJ, Pearce KH, Wisely GB, Lazar MA. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 2007;318:1786-9. [PMID: 18006707 DOI: 10.1126/science.1150179] [Cited by in Crossref: 529] [Cited by in F6Publishing: 549] [Article Influence: 33.1] [Reference Citation Analysis]
246 Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 2007;39:639-46. [PMID: 17786644 DOI: 10.1080/03602530701498737] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
247 Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, Yan Z, Spiegelman BM. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem 2007;282:30014-21. [PMID: 17702743 DOI: 10.1074/jbc.M704817200] [Cited by in Crossref: 451] [Cited by in F6Publishing: 468] [Article Influence: 28.2] [Reference Citation Analysis]
248 Rodgers JT, Puigserver P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci USA. 2007;104:12861-12866. [PMID: 17646659 DOI: 10.1073/pnas.0702509104] [Cited by in Crossref: 398] [Cited by in F6Publishing: 430] [Article Influence: 24.9] [Reference Citation Analysis]
249 Thunell S, Pomp E, Brun A. Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. Br J Clin Pharmacol 2007;64:668-79. [PMID: 17578481 DOI: 10.1111/j.0306-5251.2007.02955.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
250 Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, Spiegelman BM. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev 2007;21:770-83. [PMID: 17403779 DOI: 10.1101/gad.1525107] [Cited by in Crossref: 266] [Cited by in F6Publishing: 274] [Article Influence: 16.6] [Reference Citation Analysis]
251 Desnick RJ, Astrin KH, Anderson KE. Heme Biosynthesis and the Porphyrias. Liver Disease in Children 2007. [DOI: 10.1017/cbo9780511547409.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
252 Sadana P, Park EA. Characterization of the transactivation domain in the peroxisome-proliferator-activated receptor gamma co-activator (PGC-1). Biochem J. 2007;403:511-518. [PMID: 17284167 DOI: 10.1042/BJ20061526] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
253 Wulf A, Harneit A, Weitzel JM. T3-mediated gene expression is independent of PGC-1alpha. Mol Cell Endocrinol 2007;270:57-63. [PMID: 17382463 DOI: 10.1016/j.mce.2007.02.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
254 Pedersen TA, Bereshchenko O, Garcia-Silva S, Ermakova O, Kurz E, Mandrup S, Porse BT, Nerlov C. Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo. EMBO J 2007;26:1081-93. [PMID: 17290224 DOI: 10.1038/sj.emboj.7601563] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 3.0] [Reference Citation Analysis]
255 Bock HH, Herz J, May P. Conditional animal models for the study of lipid metabolism and lipid disorders. Handb Exp Pharmacol 2007;:407-39. [PMID: 17203665 DOI: 10.1007/978-3-540-35109-2_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
256 Tahara T, Tanaka M, Nozaki S, Jin G, Onoe H, Watanabe Y. Decrease of hepatic δ-aminolevulinate dehydratase activity in an animal model of fatigue. Biochemical and Biophysical Research Communications 2007;353:1068-73. [DOI: 10.1016/j.bbrc.2006.12.139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
257 Petrides PE. Häm und Gallenfarbstoffe. Biochemie und Pathobiochemie. [DOI: 10.1007/978-3-540-32681-6_20] [Reference Citation Analysis]
258 Blättler SM, Rencurel F, Kaufmann MR, Meyer UA. In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase. Proc Natl Acad Sci U S A 2007;104:1045-50. [PMID: 17213310 DOI: 10.1073/pnas.0610216104] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
259 To-Figueras J, Badenas C, Carrera C, Muñoz C, Milá M, Lecha M, Herrero C. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation. J Inherit Metab Dis 2006;29:580-5. [PMID: 16817012 DOI: 10.1007/s10545-006-0344-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
260 Sardh E, Rejkj??r L, Andersson DEH, Harper P. Safety, Pharmacokinetics and Pharmocodynamics of Recombinant Human Porphobilinogen Deaminase in Healthy Subjects and Asymptomatic Carriers of the Acute Intermittent Porphyria Gene Who Have Increased Porphyrin Precursor Excretion: . Clinical Pharmacokinetics 2007;46:335-49. [DOI: 10.2165/00003088-200746040-00006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
261 Wahlin S, Aschan J, Björnstedt M, Broomé U, Harper P. Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. J Hepatol 2007;46:174-9. [PMID: 17112627 DOI: 10.1016/j.jhep.2006.10.004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
262 Willis MS, Basinger AA, Fan Z, Pendyal S, Muenzer J, Hammett-stabler C. Hepatosplenomegaly in an 8-Month-Old Child. Lab Med 2006;37:665-95. [DOI: 10.1309/vyl8811l7712pejj] [Reference Citation Analysis]
263 Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006;27:728-735. [PMID: 17018837 DOI: 10.1210/er.2006-0037] [Cited by in Crossref: 822] [Cited by in F6Publishing: 864] [Article Influence: 48.4] [Reference Citation Analysis]
264 Rencurel F, Foretz M, Kaufmann MR, Stroka D, Looser R, Leclerc I, da Silva Xavier G, Rutter GA, Viollet B, Meyer UA. Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol 2006;70:1925-34. [PMID: 16988011 DOI: 10.1124/mol.106.029421] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
265 Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol 2006;135:281-92. [PMID: 16956347 DOI: 10.1111/j.1365-2141.2006.06289.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 133] [Article Influence: 7.3] [Reference Citation Analysis]
266 Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, Puigserver P. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 2006;3:429-38. [PMID: 16753578 DOI: 10.1016/j.cmet.2006.04.013] [Cited by in Crossref: 328] [Cited by in F6Publishing: 344] [Article Influence: 19.3] [Reference Citation Analysis]
267 Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem 2006;281:26540-51. [PMID: 16825189 DOI: 10.1074/jbc.M600931200] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 6.5] [Reference Citation Analysis]
268 Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2006;1763:723-36. [DOI: 10.1016/j.bbamcr.2006.05.005] [Cited by in Crossref: 325] [Cited by in F6Publishing: 341] [Article Influence: 19.1] [Reference Citation Analysis]
269 Burgess SC, Leone TC, Wende AR, Croce MA, Chen Z, Sherry AD, Malloy CR, Finck BN. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice. J Biol Chem 2006;281:19000-8. [PMID: 16670093 DOI: 10.1074/jbc.M600050200] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 5.5] [Reference Citation Analysis]
270 Rhee J, Ge H, Yang W, Fan M, Handschin C, Cooper M, Lin J, Li C, Spiegelman BM. Partnership of PGC-1α and HNF4α in the Regulation of Lipoprotein Metabolism. Journal of Biological Chemistry 2006;281:14683-90. [DOI: 10.1074/jbc.m512636200] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 3.4] [Reference Citation Analysis]
271 Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006;116:615-22. [PMID: 16511594 DOI: 10.1172/JCI27794] [Cited by in Crossref: 997] [Cited by in F6Publishing: 1046] [Article Influence: 58.6] [Reference Citation Analysis]
272 Pohjanvirta R, Niittynen M, Lindén J, Boutros PC, Moffat ID, Okey AB. Evaluation of various housekeeping genes for their applicability for normalization of mRNA expression in dioxin-treated rats. Chem Biol Interact 2006;160:134-49. [PMID: 16466705 DOI: 10.1016/j.cbi.2006.01.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
273 Reddy JK, Guo D, Jia Y, Yu S, Rao MS. Nuclear receptor transcriptional coactivators in development and metabolism. Nuclear Receptors in Development. Elsevier; 2006. pp. 389-420. [DOI: 10.1016/s1574-3349(06)16012-3] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
274 Pihlajamäki J, Patti ME. Chapter 12 Regulation of PGC-1 in humans with insulin resistance and type 2 diabetes: Functional implications. New Transcription Factors and their Role in Diabetes and its Therapy 2006. [DOI: 10.1016/s1569-2566(06)05012-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
275 Scarpulla RC. Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 2006;97:673-83. [DOI: 10.1002/jcb.20743] [Cited by in Crossref: 356] [Cited by in F6Publishing: 372] [Article Influence: 20.9] [Reference Citation Analysis]
276 Phillips JD, Kushner JP. Fast track to the porphyrias. Nat Med 2005;11:1049-50. [PMID: 16211036 DOI: 10.1038/nm1005-1049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
277 Li D. PGC-1alpha: looking behind the sweet treat for porphyria. Cell 2005;122:487-9. [PMID: 16122414 DOI: 10.1016/j.cell.2005.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]